<?xml version="1.0" encoding="UTF-8"?>

<?xml-stylesheet type="text/xsl" href="/static/oaitohtml.xsl"?>

<!--
<?xml-stylesheet type="text/xsl" href="/oaitohtml.xsl"?>
-->

<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <responseDate>2026-10-12T01:35:07Z</responseDate>
    <request verb="GetRecord" metadataPrefix="oai_dc" identifier="10.57760/sciencedb.12515" >https://www.scidb.cn/oai</request>
<GetRecord>
    <record>
    <header >
    <identifier>10.57760/sciencedb.12515</identifier>
    <datestamp>2023-11-21T11:03:57Z</datestamp>
</header>
    <metadata>
        
<oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:date>2023-11-21</dc:date>
  <dc:title>The&amp;nbsp;Practice&amp;nbsp;of&amp;nbsp;Quality Control&amp;nbsp;of Full-course Administration for intravenous antineoplasitc Agents in a Hospital</dc:title>
  <dc:identifier>doi:10.57760/sciencedb.12515</dc:identifier>
  <dc:language>en</dc:language>
  <dc:description>Objective&amp;nbsp;To provide reference for the rational use of intravenous antineoplastic agents. Methods&amp;nbsp;Through&amp;nbsp;summarizing the problems existing in the use of intravenous&amp;nbsp;antineoplasitc agents&amp;nbsp;in our hospital, the corresponding measures were formulated. The quality management team was established; then the system was updated and the process was optimized;&amp;nbsp;the information system was improved; the training of personnel was also strengthened. And the comprehensive quality control of intravenous anti-tumor drugs were implemented by before, during and after administration.&amp;nbsp;The quality control effect was compared before and after the implementation. Results&amp;nbsp;Firstly, medication safety for patients was improved after the implementation of quality control of the whole process of drug administration. On the one hand,&amp;nbsp;the rationality of medical orders were ensured and the batches of infusion were correctly&amp;nbsp;divided; On the other hand, the accuracy of drug administration wad greatly improved.&amp;nbsp;8 months later, the qualified rates of the use of clinical special infusion sets, the infusion time and the interval time of sequential dependent anti-tumor drugs increased from 49.5%, 64.3%, 39.0% before implementating quality control&amp;nbsp;of full-course administration (November 2020-June 2021) to 97.5%, 75.5% and 70.6% (P&amp;lt;0.01) after implementating quality control&amp;nbsp;of full-course administration&amp;nbsp;(July 2021-February 2022). Secondly, the satisfaction of clinical nurses was improved through the labeling of finished infusion labels and the popular science knowledge publicity of wechat public account. Conclusions&amp;nbsp;The quality control mode of full-course administration for antineoplastic agents can promote the rational use of intravenous antineoplastic drugs.&amp;nbsp;</dc:description>
  <dc:subject>Intravenous antineoplasitc agents; Full-course administration; Quality control</dc:subject>
  <dc:creator>Wenjing Zhu</dc:creator>
  <dc:creator>Junping Wang</dc:creator>
  <dc:rights>PUBLIC</dc:rights>
  <dc:rights>https://opendatacommons.org/licenses/pddl/1-0/</dc:rights>
  <dc:type>dataset</dc:type>
  <dc:publisher>Science Data Bank</dc:publisher>
</oai_dc:dc>

    </metadata>
</record>
</GetRecord>
</OAI-PMH>